ESPERITE Group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine established in 2000.
ESPERITE is a diversified biotech global group specialised in Immunotherapy, Regenerative Medicine and Precision Medicine. Established in 2000, Esperite is a holding company , listed at Euronext Amsterdam and Paris. ESPERITE invests in companies able to transform the power of state-of-the-art technologies and scientific advancements into high quality products. Therefore, the company wants to bring the future of medicine to customers today at an affordable price.
ESPERITE provides early access to key information and knowledge, improving the way we address human diseases and genetic disorders. The company attains the highest quality and ethical standards in the pursuit of its vision to bring the benefits of personalized medicine to society.
The realization of longer life spans and delayed childbearing in an aging population is prompting society into a more proactive and responsible approach to healthcare. This also applies to governments and health insurers, in need of affordable solutions to cope with increasing healthcare-related costs. ESPERITE’s pioneering spirit fuels the application of breakthrough disruptive technologies. This will develop innovative products for commercial leadership, setting higher and more efficient healthcare standards.